MACC1 serves as an important biomarker and therapeutic target in ESCC, and it promotes invasion and lymph node metastasis primarily through the PTEN/PI3K/Akt and AMPK-ULK1 signaling pathways 28, 29. This evidence concerns the gene PTEN and esophageal squamous cell carcinoma.